{"id":"https://openalex.org/W2043908414","doi":"https://doi.org/10.1021/jm2011172","title":"Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)","display_name":"Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)","alternate_titles":[],"publication_year":2011,"publication_date":"2011-11-09","ids":{"openalex":"https://openalex.org/W2043908414","doi":"https://doi.org/10.1021/jm2011172","mag":"2043908414","pmid":"https://pubmed.ncbi.nlm.nih.gov/22070629"},"language":"en","primary_location":{"id":"doi:10.1021/jm2011172","doi":"https://doi.org/10.1021/jm2011172","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm2011172","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2043908414"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071887799","display_name":"Matthew O. Duffey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew O. Duffey","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States. matthew.duffey@mpi.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States. matthew.duffey@mpi.com","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025958753","display_name":"Tricia J. Vos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tricia J. Vos","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063246367","display_name":"Ruth Adams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruth Adams","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011581117","display_name":"Jennifer Alley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Alley","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036159185","display_name":"Justin Anthony","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Anthony","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006308195","display_name":"Cynthia Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia Barrett","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070348906","display_name":"Indu Bharathan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Indu Bharathan","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090670345","display_name":"Douglas Bowman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Bowman","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112342566","display_name":"Nancy J. Bump","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy J. Bump","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015510005","display_name":"Ryan Chau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Chau","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078799522","display_name":"Courtney A. Cullis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney Cullis","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041403992","display_name":"Denise L. Driscoll","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denise L. Driscoll","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050239518","display_name":"Amy M. Elder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Elder","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055996360","display_name":"Nancy E. Forsyth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Forsyth","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073497802","display_name":"Jonathan Frazer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Frazer","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101502003","display_name":"Jianping Guo","orcid":"https://orcid.org/0000-0001-5202-3712","observed_orcids":["https://orcid.org/0000-0001-5202-3712"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianping Guo","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081085309","display_name":"Luyi Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luyi Guo","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083819346","display_name":"Marc L. Hyer","orcid":"https://orcid.org/0009-0003-3737-1542","observed_orcids":["https://orcid.org/0009-0003-3737-1542"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc L. Hyer","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045496263","display_name":"David A. Janowick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Janowick","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112445064","display_name":"Bheemashankar A. Kulkarni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bheemashankar Kulkarni","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005809084","display_name":"Sujen Lai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Su-Jen Lai","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020808562","display_name":"Kerri Lasky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerri Lasky","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gang Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gang Li","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100336923","display_name":"Jing Li","orcid":"https://orcid.org/0000-0002-3977-1641","observed_orcids":["https://orcid.org/0000-0002-3977-1641"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Li","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025835300","display_name":"Debra Liao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra Liao","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065255763","display_name":"Jeremy Little","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy Little","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104387112","display_name":"Bo Peng","orcid":"https://orcid.org/0009-0009-0527-5322","observed_orcids":["https://orcid.org/0009-0009-0527-5322"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bo Peng","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010162365","display_name":"Mark G. Qian","orcid":"https://orcid.org/0000-0001-6140-973X","observed_orcids":["https://orcid.org/0000-0001-6140-973X"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark G. Qian","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075928380","display_name":"Dominic J. Reynolds","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dominic J. Reynolds","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024139435","display_name":"Mansoureh Rezaei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mansoureh Rezaei","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022609500","display_name":"Margaret Porter Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Porter Scott","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038207734","display_name":"Todd B. Sells","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd B. Sells","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027501007","display_name":"Vaishali Shinde","orcid":"https://orcid.org/0000-0001-5075-9283","observed_orcids":["https://orcid.org/0000-0001-5075-9283"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vaishali Shinde","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060053847","display_name":"Qiuju Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiuju Judy Shi","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045357859","display_name":"Michael D. Sintchak","orcid":"https://orcid.org/0000-0003-2947-6566","observed_orcids":["https://orcid.org/0000-0003-2947-6566"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D. Sintchak","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111919820","display_name":"Fran\u00e7ois Soucy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francois Soucy","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075185822","display_name":"Kevin T. Sprott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin T. Sprott","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055671586","display_name":"Stephen G. Stroud","orcid":"https://orcid.org/0009-0005-3684-5050","observed_orcids":["https://orcid.org/0009-0005-3684-5050"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen G. Stroud","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038891406","display_name":"Michelle Tighe Nestor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Nestor","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048389541","display_name":"Irache Visiers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irache Visiers","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024644355","display_name":"Gabriel S. Weatherhead","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel Weatherhead","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090307804","display_name":"Yingchun Ye","orcid":"https://orcid.org/0000-0001-5408-6741","observed_orcids":["https://orcid.org/0000-0001-5408-6741"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yingchun Ye","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018443768","display_name":"Natalie Roy D\u2019Amore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie D\u2019Amore","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts\r02139, United States","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts#R#02139, United States","institution_ids":["https://openalex.org/I4405270001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071887799"],"corresponding_institution_ids":["https://openalex.org/I4405270001"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.6232,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.60835593,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"55","issue":"1","first_page":"197","last_page":"208"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.7271000146865845,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.7271000146865845,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.2621999979019165,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plk1","display_name":"PLK1","score":0.9879999756813049},{"id":"https://openalex.org/keywords/plk1-inhibitors","display_name":"PLK1 inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/orally-bioavailable-drugs","display_name":"orally bioavailable drugs","score":0.7390000224113464},{"id":"https://openalex.org/keywords/mitotic-arrest","display_name":"mitotic arrest","score":0.9800000190734863},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.7400000095367432},{"id":"https://openalex.org/keywords/colon-cancer-xenografts","display_name":"colon cancer xenografts","score":0.7950000166893005},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7369999885559082},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.911605179309845},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5832469463348389},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.5332813858985901},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4931413531303406},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4772101044654846},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.32490503787994385},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.23093706369400024},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000097869","descriptor_name":"Polo-Like Kinase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007769","descriptor_name":"Lactams","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007769","descriptor_name":"Lactams","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007769","descriptor_name":"Lactams","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008938","descriptor_name":"Mitosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013871","descriptor_name":"Thiones","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D013871","descriptor_name":"Thiones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013871","descriptor_name":"Thiones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm2011172","doi":"https://doi.org/10.1021/jm2011172","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm2011172","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:22070629","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22070629","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1516211547","https://openalex.org/W1584172336","https://openalex.org/W1600720931","https://openalex.org/W1864382350","https://openalex.org/W1926859915","https://openalex.org/W1933723496","https://openalex.org/W1967886589","https://openalex.org/W1972644607","https://openalex.org/W2003821692","https://openalex.org/W2004981153","https://openalex.org/W2012921486","https://openalex.org/W2020516698","https://openalex.org/W2021246859","https://openalex.org/W2021252415","https://openalex.org/W2022698699","https://openalex.org/W2025540821","https://openalex.org/W2028306553","https://openalex.org/W2029108033","https://openalex.org/W2035925505","https://openalex.org/W2036361742","https://openalex.org/W2041238848","https://openalex.org/W2042610929","https://openalex.org/W2051210198","https://openalex.org/W2059980106","https://openalex.org/W2060322578","https://openalex.org/W2060548501","https://openalex.org/W2063461424","https://openalex.org/W2078308664","https://openalex.org/W2082087067","https://openalex.org/W2110864471","https://openalex.org/W2114135705","https://openalex.org/W2127019295","https://openalex.org/W2130968156","https://openalex.org/W2133350827","https://openalex.org/W2142904932","https://openalex.org/W2161761124","https://openalex.org/W2167003908","https://openalex.org/W2319415470"],"related_works":["https://openalex.org/W7166727452","https://openalex.org/W2121344811","https://openalex.org/W7117295235","https://openalex.org/W2159661782","https://openalex.org/W2028306553","https://openalex.org/W2147351626","https://openalex.org/W4243869831","https://openalex.org/W2059980106","https://openalex.org/W4319083917","https://openalex.org/W2912313519"],"abstract_inverted_index":{"This":[0],"article":[1],"describes":[2],"the":[3],"discovery":[4],"of":[5,8,11,17,27,42],"a":[6,63],"series":[7,21],"potent":[9],"inhibitors":[10],"Polo-like":[12],"kinase":[13],"1":[14],"(PLK1).":[15],"Optimization":[16],"this":[18],"benzolactam-derived":[19],"chemical":[20],"produced":[22],"an":[23],"orally":[24],"bioavailable":[25],"inhibitor":[26],"PLK1":[28],"(12c,":[29],"MLN0905).":[30],"In":[31],"vivo":[32],"pharmacokinetic-pharmacodynamic":[33],"experiments":[34],"demonstrated":[35],"prolonged":[36],"mitotic":[37],"arrest":[38],"after":[39],"oral":[40],"administration":[41],"12c":[43],"to":[44],"tumor":[45,57,66],"bearing":[46],"nude":[47,54],"mice.":[48],"A":[49],"subsequent":[50],"efficacy":[51],"study":[52],"in":[53,62],"mice":[55],"achieved":[56],"growth":[58],"inhibition":[59],"or":[60],"regression":[61],"human":[64],"colon":[65],"(HT29)":[67],"xenograft":[68],"model.":[69]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2043908414","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
